Point72 Hong Kong LTD Amgen Inc Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.15 Million - $2.42 Million	8,404 New	8,404 $2.42 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $7.17 Million - $8.09 Million	-31,951 Reduced 99.76%	78 $18,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $5.01 Million - $5.57 Million	21,701 Added 210.12%	32,029 $7.79 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $2.01 Million - $2.22 Million	9,169 Added 791.11%	10,328 $2.5 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.5 Million - $1.76 Million	-7,087 Reduced 85.94%	1,159 $246,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.78 Million - $2.12 Million	8,246 New	8,246 $1.9 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $65,079 - $79,861	-329 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $15,308 - $20,302	84 Added 34.29%	329 $67,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $46,356 - $59,584	245 New	245 $59,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $40,045 - $47,982	-230 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $266,386 - $312,265	-1,598 Reduced 87.42%	230 $42,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $330,630 - $372,692	1,828 New	1,828 $347,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $48,545 - $54,729	-262 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $21,254 - $23,873	128 Added 95.52%	262 $48,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $22,703 - $26,532	134 New	134 $23,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.